论文部分内容阅读
卵巢癌属于对抗肿瘤化疗有效的恶性肿瘤,然而必要的疗程难以确定,缺乏临床缓解或早期复发以及疗程结束时间的标准。许多病例虽残余肿瘤极小,由于过早停药仍出现复发。弥漫性、小结节状的转移迄今通过肿瘤标记和放射方法均不能证实。经再次剖腹探查或腹腔镜检取材作细胞学和组织学检查是目前估价疗效的最可靠方法。材料及方法。1976～1982年 MAD 妇科医院73例卵巢癌患者(Ⅰ期13例、Ⅱ期9例及Ⅲ期51例)首次治疗(手术、化疗和放疗)结束,临床证实无
Ovarian cancer is a malignant tumor effective against antitumor chemotherapy, but the necessary course of treatment is difficult to determine, the lack of clinical remission or early recurrence and the end of the course of treatment standards. In many cases, although the residual tumor is extremely small, recurrence still occurs due to premature withdrawal. Diffuse, nodular metastases have so far not been demonstrated by both tumor labeling and radiological methods. Re-laparotomy or laparoscopy for cytological and histological examination is the most reliable method of assessing the efficacy. Materials and methods. From 1976 to 1982, 73 patients with ovarian cancer (13 in stage I, 9 in stage II and 51 in stage III) of MAD gynecological hospital were enrolled in the first treatment (surgery, chemotherapy and radiotherapy)